INS and metabolic syndrome: Although the exact pathophysiology of MetS remains to be elucidated, endothelial dysfunction, reduced insulin sensitivity, and inflammation are important (Abdul‐Ghani et al., 2019; Einarson et al., 2018; Swarup et al., 2021).